Arzneistoffe

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997

2024

(¹⁷⁷Lu)Lutetiumvipivotidtetraxetan (Pluvicto^®)
Abaloparatid (Eladynos^®)
Artesunat (Artesunate Amivas)
Capivasertib (Truqap^®)
Crovalimab (Piasky^®)
Danicopan (Voydeya^®)
Delgocitinib (Anzupgo^®)
Efanesoctocog alfa (Altuvoct™)
Efbemalenograstim alfa (Ryzneuta^®)
Elafibranor (Iqirvo^®)
Elranatamab (Elrexfio^®)
Enmetazobactam (Exblifep^®)
Etrasimod (Velsipity^®)
Fezolinetant (Veoza™)
Fruquintinib (Fruzaqla^®)
Futibatinib (Lytgobi^®)
Insulin icodec (Awiqli^®)
Iptacopan (Fabhalta^®)
Linzagolix (Yselty^®)
Meropenem-Vaborbactam (Vaborem^®)
Mirvetuximab-Soravtansin (Elahere^®)
Momelotinib (Omjjara^®)
Omaveloxolon (Skyclarys™)
Pegzilarginase (Loargys^®)
Pirtobrutinib (Jaypirca^®)
Quizartinib (Vanflyta^®)
Rekombinantes ADAMTS13 (Adzynma^®)
Rezafungin (Rezzayo^®)
Rozanolixizumab (Rystiggo^®)
Sotatercept (Winrevair^®)
Sparsentan (Filspari^®)
Tislelizumab (Tevimbra^®)
Tofersen (Qalsody™)
Ublituximab (Briumvi^®)
Vadadustat (Vafseo^®)
Vamorolon (Agamree^®)
Vibegron (Obgemsa^®)
Zilucoplan (Zilbrysq^®)
Zolbetuximab (Vyloy™)

Mehr von Avoxa

Unsere Newsletter halten Sie immer auf dem Laufenden.

JETZT ABONNIEREN

JETZT ABONNIEREN